Compagnie Lombard Odier SCmA’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 526 |
|
|
2024
Q4 | – | Sell |
-1,847
| Closed | -$26.3K | – | 500 |
|
|
2024
Q3 | $26.3K | Hold |
1,847
| – | – | ﹤0.01% | 378 |
|
|
2024
Q2 | $23.9K | Buy |
+1,847
| New | +$23.9K | ﹤0.01% | 376 |
|
|
2021
Q1 | – | Sell |
-30
| Closed | -$1K | – | 690 |
|
|
2020
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 551 |
|
|
2020
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 507 |
|
|
2020
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 507 |
|
|
2020
Q1 | $0 | Hold |
30
| – | – | ﹤0.01% | 584 |
|
|
2019
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 503 |
|
|
2019
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 508 |
|
|
2019
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 503 |
|
|
2019
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 548 |
|